Fragoulakis, Vassilis <br/><br/>
Cost-minimization analysis of the treatment of patients with metastatic colorectal cancer in Greece.  [electronic resource] 

 -  Clinical therapeutics  Oct 2012 
 - 2132-42 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2012.09.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--economics<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--economics<br/>Cetuximab<br/>Colorectal Neoplasms--drug therapy<br/>Cost Savings<br/>Drug Costs<br/>ErbB Receptors--antagonists & inhibitors<br/>Greece<br/>Hospital Costs<br/>Humans<br/>Models, Economic<br/>Models, Statistical<br/>Neoplasm Metastasis<br/>Panitumumab<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>ras Proteins--genetics